New Health Sciences seeks to bring about radical improvements in patient care through the acquisition, development, and commercialization of innovative technologies in transfusion medicine.
The candidate will be part of the product realization team and be responsible for user specifications, design and clinical validation activities.
Read More >
March 21st, 2015|Comments Off on NHSi Closes Financing
New Health Sciences has closed an additional $6.0 million Series B financing […]
January 5th, 2015|Comments Off on NHSi Hires VP, Research and Clinical Affairs
New Health Sciences has hired Andrew Dunham, PhD as Chief Scientific Officer […]
Read All News >